Minheui Yu

Trajectories of Albuminuria and Non‐Albumin Proteinuria After Sequential Addition of Finerenone for Residual Albuminuria Despite Established SGLT2 Inhibitor Therapy in Diabetic Kidney Disease: A Real‐World Cohort Study

ABSTRACT Aims CONFIDENCE evaluated simultaneous initiation of finerenone and an SGLT2 inhibitor (SGLT2i). We examined 12‐month trajectories of albuminuria and non‐albumin proteinuria after finerenone was added to established SGLT2i therapy. Materials and Methods This single‐centr...